VGT Stock Recent News

It looks like artificial intelligence (AI) is more than the latest fad. The technology is becoming an integral part of how people do things, from work to play, offering solutions to simplify complex activities.

QQQ and IBIT led last week's $17B ETF inflows, as investors piled into tech, Bitcoin, and gold amid market resilience.

Investing in exchange-traded funds (ETFs) is usually associated with safe and stable long-term investing. But not all ETFs are the same.

The S&P 500 was down by as much as 19% from its all-time high after President Trump announced his "Liberation Day" tariffs on April 2. But it erased those losses since then because several countries have come to the table to negotiate new trade deals and the federal Court of International Trade ruled many of the tariffs were illegal, lowering the odds of an economic downturn.

If the recent stock market rollercoaster has you feeling nauseated, you're not alone. Investor sentiment has been swinging wildly in recent months, with 43% of investors feeling optimistic about the market in January to only 19% in March to around 38% most recently, according to weekly surveys from the American Association of Individual Investors.

Whether you're new to investing or have years of experience, buying exchange-traded funds (ETFs) can be a smart way to build your portfolio. They offer instant diversification and can even give you targeted exposure to specific sectors.

MINNEAPOLIS--(BUSINESS WIRE)--Vergent Bioscience, a clinical-stage biotechnology company developing tumor targeted imaging agents, announced new data being presented at the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting. These results demonstrate that using intraoperative molecular imaging (IMI) with abenacianine for injection (VGT-309), the company's investigational tumor-targeted fluorescent imaging agent, during lung surgery has the potential to help optimize tumor resectio.

VGT offers slightly lower fees and broader tech sector exposure, but is more top-heavy and excludes major tech names like Amazon, Google, and Meta. QQQ provides access to the full Magnificent 7, is less top-heavy, and includes non-tech growth leaders, but at a slightly higher expense ratio. VGT has outperformed QQQ over the past decade, but its long-term performance since inception has been below that of QQQ.

VGT's extreme concentration in its top three holdings undermines the diversification benefit I expect from an ETF. Current tech sector valuations are historically high, leaving little room for further multiple expansion and skewing risk to the downside. Healthcare and other sectors offer more attractive entry points, with lower valuations and solid earnings growth potential.

The Nasdaq Composite (^IXIC 0.52%) closed Wednesday at 19,146.81 -- a staggering 29.5% rally from its 52-week intraday low of 14,784.03 on April 7.